Study of Human Dopamine Sulfotransferases Based on Gene Expression Programming

Chemical Biology and Drug Design

Volumn 78, Issue 3, 2011, Pages 370-377

  Si, Hongzong ^a   Zhao, Jiangang ^b   Cui, Lianhua ^a   Lian, Ning ^c   Feng, Hanlin ^d   Duan, Yun Bo ^a   Hu, Zhide ^e  

^a QINGDAO UNIVERSITY   (China)

^b GANSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c JIANGSU UNIVERSITY OF TECHNOLOGY   (China)

^d Shenzhen Neptunus Pharmaceutical Technical Center   (China)

^e LANZHOU UNIVERSITY   (China)

Author keywords

Gene expression programming; Heuristic method; Km; Quantitative structure activity relationship; Sulfotransferases

Indexed keywords

1 BROMO 3,4 DIHYDROXYBENZENE; 2 HYDROXYESTRADIOL; 2,3 DIHYDROXYBENZALDEHYDE; 2,3 NAPHTHALENEDIOL; 3 CHLOROCATECHOL; 3 FLUOROPYROCATECHOL; 3 METHOXYCATECHOL; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 CHLOROCATECHOL; 4 CHLOROPHENOL; 4 ISOPROPYLCATECHOL; 4 PHENYLAZOPHENOL; APOMORPHINE; BENZENE DERIVATIVE; CATECHIN; CATECHOL DERIVATIVE; DOBUTAMINE; DOPAMINE; DOPAMINE SULFOTRANSFERASE; ETHYL PARABEN; ISOPRENALINE; ISOQUINOLINE DERIVATIVE; METHYLDIHYDROXYTETRAHYDROISOQUINOLINE; NAPHTHALENE DERIVATIVE; NORADRENALIN; PHENOL DERIVATIVE; PROPYL PARABEN; SULFOTRANSFERASE; TETRACHLOROCATECHOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALGORITHM; ARTICLE; CHEMICAL BOND; GENE EXPRESSION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STUDY;

ARYLSULFOTRANSFERASE; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; NEURAL NETWORKS (COMPUTER); QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SULFOTRANSFERASES;

EID: 80051584778     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01155.x     Document Type: Article

References (50)

1. Coughtrie M.W., Sharp S., Maxwell K., Innes N.P. (1998) Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact;109:3-27.
2. Weinshilboum R.M., Otterness D.M., Aksoy I.A., Wood T.C., Her C., Raftogianis R.B. (1997) Sulfation and sulfotransferases 1: sulfotransferase molecular. biology: cDNAs and genes. FASEB J;11:3-14.
3. Duffel M.W. (1997) Comprehensive Toxicology (Guengerich F.P., editor). Oxford: Elsevier Science Ltd; p. 365-383.
4. Reiter C., Mwaluko G., Dunnette J., Van Loon J., Weinshilboum R. (1983) Thermolabile and thermostable human platelet phenol sulfotransferase: substrate specificity and physical separation. Naunyn Schmiedebergs Arch Pharmacol;324:140-147.
5. Dousa M.K., Tyce G.M. (1988) Free and conjugated plasma catecholamines, DOPA and 3-O-methyldopa in humans and in various animal species. Proc Soc Exp Biol Med;188:427-434.
6. Li J.Z., Liu H.X., Yao X.J., Liu M.C., Hu Z.D., Fan B.T. (2007) Quantitative structure.activity relationship study of acyl ureas as inhibitors of human liver glycogen phosphorylase using least squares support vector machines. Chemometr Intell Lab;87:139-146.
7. Kraker J.J., Hawkins D.M., Basak S.C., Natarajan R., Mills D. (2007) Quantitative structure.activity relationship (QSAR) modeling of juvenile hormone activity: comparison of validation procedures. Chemometr Intell Lab Syst;87:33-42.
8. Arakawa M., Hasegawa K., Funatsu K. (2006) QSAR study of anti-HIV HEPT analogues based on multi-objective genetic programming and counter-propagation neural network. Chemometr Intell Lab Syst;83:91-98.
9. Shen Q., Jiang J.H., Shen G.L., Yu R.Q. (2006) Ridge estimated orthogonal signal correction for data preprocessing prior to PLS modeling: QSAR studies of cyclooxygenase-2 inhibitors. Chemometr Intell Lab Syst;82:44-49.
10. Hansch C., Kurup A., Garg R., Gao H. (2001) Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. Chem Rev;101:619-672.
11. Hansch C., Leo A., Mekapati S.B., Kurup A. (2004) QSAR and ADME. Bioorg Med Chem;12:3391-3400.
12. Du Q.S., Huang R.B., Chou K.C. (2008) Review: recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. Curr Protein Pept Sci;9:248-259.
13. Kubinyi H. (1997) QSAR and 3D QSAR in drug design. I. Methodology. Drug Discov Today;2:457-467.
14. Kurup S.B.A., Mekapati R., Garg C.H. (2003) HIV-1 protease inhibitors: a. comparative QSAR analysis. Curr Med Chem;10:1679-1688.
15. Liu H.X., Yao X.J., Liu M.C., Hu Z.D., Fan B.T. (2004) Prediction of the isoelectric point of an amino acid based on GA-PLS and SVMs. J Chem Inf Comput Sci;44:161-167.
16. Prado-Prado F.J., Martinez de la Vega O., Uriarte E., Ubeira F.M., Chou K.C., Gonzalez-Diaz H. (2009) Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg Med Chem;17:569-575.
17. Wei H., Wang C.H., Du Q.S., Meng J., Chou K.C. (2009) Investigation into adamantane-based M2 inhibitors with FB-QSAR. Med Chem;5:305-317.
18. Katritzky A.R., Lobanov V.S., Karelson M. (1994) Reference Manual, Version 20. Gainesville, FL: University of Florida.
19. Katritzky A.R., Lobanov V.S., Karelson M. (1995) QSAR: the correlation and quantitative prediction of chemical and physical properties from structure. Chem Soc Rev;24:279-287.
20. Oblak M., Randic M., Solmajer T. (2000) Quantitative structure-activity relationship of flavonoid analogues. 3. Inhibition of p56lck protein tyrosine kinase. J Chem Inf Comput Sci;40:994-1001.
21. Katritzky A.R., Tatham D.B. (2001) Melting points of potential ionic liquids (imidazolium bromides and benzimidazolium bromides) using the CODESSA program. J Chem Inf Comput Sci;41:1162-1176.
22. Si H.Z., Wang T., Zhang K.J., Duan Y.B., Yuan S.P., Fu A.P., Hu Z.D. (2007) Quantitative structure activity relationship model for predicting the depletion percentage of skin allergic chemical substances of glutathione. Anal Chim Acta;591:255-264.
23. Chou K.C., Wei D.Q., Zhong W.Z. (2003) Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun;308:148-151.
24. He Z.S., Zhang J., Shi X.H., Hu L.L., Kong X.Y., Cai Y.D., Chou K.C. (2010) Predicting drug-target interaction networks based on functional groups and biological features. PLoS ONE;5:e9603.
25. Sirois S., Wei D.Q., Du Q.S., Chou K.C. (2004) Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. J Chem Inf Comput Sci;44:1111-1122.
26. Chou K.C., Wei D.Q., Du Q.S., Sirois S., Zhong W.Z. (2006) Review: progress in computational approach to drug development against SARS. Curr Med Chem;13:3263-3270.
27. Chou K.C., Shen H.B. (2009) Review: recent advances in developing web-servers for predicting protein attributes. Nat Sci;2:63-92.
28. Chou K.C. (1993) A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J Biol Chem;268:16938-16948.
29. Chou K.C. (1996) Review: prediction of HIV protease cleavage sites in proteins. Anal Biochem;233:1-14.
30. Chou K.C. (2004) Review: structural bioinformatics and its impact to biomedical science. Curr Med Chem;11:2105-2134.
31. Chou K.C. (2004) Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. Biochem Biophys Res Commun;316:636-642.
32. Chou K.C. (2004) Molecular therapeutic target for type-2 diabetes. J Proteome Res;3:1284-1288.
33. Chou K.C. (1992) Energy-optimized structure of antifreeze protein and its binding mechanism. J Mol Biol;223:509-517.
34. Chou K.C., Zhou G.P. (1982) Role of the protein outside active site on the diffusion-controlled reaction of enzyme. J Am Chem Soc;104:1409-1413.
35. Zhou G.P., Deng M.H. (1984) An extension of Chou's graphical rules for deriving enzyme kinetic equations to system involving parallel reaction pathways. Biochem J;222:169-176.
36. Wu Z.C., Xiao X., Chou K.C. (2010) 2D-MH: a web-server for generating graphic representation of protein sequences based on the physicochemical properties of their constituent amino acids. J Theor Biol;267:29-34.
37. Chou K.C. (1988) Review: low-frequency collective motion in biomacromolecules and its biological functions. Biophys Chem;30:3-48.
38. Chou K.C., Shen H.B. (2007) Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides. Biochem Biophys Res Commun;357:633-640.
39. Ferreira C. (2006) Gene Expression Programming: Mathematical Modeling by an Artificial Intelligence, 2nd edn. Germany: Springer-Verlag.
40. Ozlem T., Keskin M.E. (2005) Evaporation estimation using gene expression programming. J Appl Sci;5:508-512.
41. Baykasoglu A., Dereli T., Tanis S. (2004) Prediction of cement strength using soft computing techniques. Cement and Concrete Res;34:2083-2090.
42. Rana D., Anne C., Margarete N.J.W., Harren J., Alan M.H., Sandeep M., Anne H., Jyrki T., Robert M.C., Gary R.M., Michael W.H.C. (1999) X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. J Biol Chem;274:37862-37868.
43. Stewart J.P.P. (1989) QCPE, No 455. Bloomington, IN: Indiana University.
44. Hu R.J., Liu H.X., Zhang R.S., Xue C.X., Yao X.J., Liu M.C., Hu Z.D., Fan B.T. (2005) QSPR prediction of GC retention indices for nitrogen-containing polycyclic aromatic compounds from heuristically computed molecular descriptors. Talanta;68:31-39.
45. Ferreira C. (2001) Gene expression programming: a new adaptive algorithm for solving problems. Complex Syst;13:87-129.
46. Ivanciuc O., Ivanciuc T., Balaban A.T. (2002) QSAR models for the dermal penetration of polycyclic aromatic hydrocarbons. IEJMD;1:559-571.
47. Weast R.C. (1974) Handbook of Chemistry and Physics. Cleveland, OH: CRC Press; p. F-112.
48. Stanton D.T., Jurs P.C. (1990) Development and use of charged partial surface area structural descriptors in computerassisted QSPR studies. Anal Chem;62:2323-2329.
49. Stanton D.T., Egolf L.M., Jurs P.C., Hicks M.G. (1992) Computer-assisted prediction of normal boiling points of pyrans and pyrroles. J Chem Inf Comput Sci;32:306-316.
50. Si H.Z., Yuan S.P., Zhang K.J., Fu A.P., Duan Y.B., Hu Z.D. (2008) Quantitative structure activity relationship study on EC50 of anti-HIV drugs. Chemometr Intell Lab Syst;90:15-24.